Search

Continuous processing for small molecule products has been a hot topic for years, but where does the industry stand with it today?

Biopharma companies procrastinating on sustainability measures risk falling behind, according to Cytiva’ Global Biopharma Sustainability Review.

A look back at some of the most inspiring quotes from our interviews.

From developments in cell culture media to enhancing the potency of monoclonal antibodies – check out our free eBook.

The analytical complexities that come with oligonucleotide manufacturing are difficult, but not impossible.

AstraZeneca’s FluMist is the first flu vaccine to be approved for self-administration.

Here’s how an mRNA-based approach can overcome the development challenges of designing protein therapeutics.

We look at three recent studies that demonstrate the versatility of hot melt extrusion for developing patient-centric dosage forms.

Supply chain lessons have been learned since COVID-19, so why are we seeing so many drug shortages?

Researchers use AI to reprogram glioblastoma cancer cells